Gene-Modified Stem Cell Therapy for Children With Autosomal Recessive Osteopetrosis (ARO)

NCT07665021 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Osteopetrosis

Interventions

GENETIC: FT024

Sponsor

Fondazione Telethon

Collaborators

[object Object]